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. Article 20 of the WHO FCTC deals with research, surveillance and exchange of information on tobacco products including smokeless tobacco (SLT). In the context of SLT control, the Article mandates to carry out appropriate scientific national research and the establishment of surveillance mechanisms. It also mandates undertaking of programmes that address the magnitude, patterns, determinants, related social, economic and health indicators and consequences of SLT consumption. This Article also includes information regarding how to facilitate the cooperative exchange of SLT control-related information and provision of support, with special focus on developing Parties 
Material & Methods
All 180 Parties to the Convention were included in the analysis. The European Union as a Party was excluded (as it represents a group of countries that are already included in 180 Parties).
Data sources:
(i) Tobacco use prevalence among adults and adolescents was obtained from the health survey reports of individual countries, from Global Tobacco Surveillance System -Global Adult Tobacco Survey, Global Youth Tobacco Survey, Demographic Health Survey, WHO STEPwise NCD Risk Factors survey and Global School Health Survey reports or published data in indexed journals and secondary analysis from the original sources [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . We included national and subnational data from all Parties, provided that they met indicator definition ( Table I) . National data of a country were included if the sample was designed to estimate their national prevalence either by combining their regional estimates or rough national estimates. Subnational estimates were defined if this sample was drawn from one such geographic region of the country. (ii) Data on health impacts of SLT use (morbidity and mortality) were obtained from published cohort and case-control studies [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . (iii) Data on economics of SLT control were obtained from two sources: (a) Comparable tax data on SLT products obtained from the WHO Global Tobacco Epidemic Reports of 2015 and 2017 8, 9 . Data reported by countries where methodology was not provided, were excluded from this study; (b) Costs incurred attributable to SLT use and incomes from SLT were collected from country reports commissioned by Governments or WHO [36] [37] [38] [39] . (Tables II & III) . (Tables II & III) .
Results & Discussion
Overall SLT use prevalence: Overall, 92 per cent of the Parties (n=166) had SLT use prevalence among adults or adolescents either at national or subnational level (Table II) . Thirty seven Parties (20.5%) were high-burden Parties where the prevalence of SLT use was 10 per cent or higher among adolescents or adults (Tables II & III) .
Smokeless tobacco-related health indicators: Only 10 Parties (Bangladesh, India, Iran, Norway, Pakistan, Sweden, Sudan, Saudi Arabia, South Africa and Yemen) had data on risks known for major diseases attributable to SLT use (Table II) Economic indicators related to SLT use: Thirty five Parties had comparable price and tax incidence rates for SLT at one point of time and all are recent (Table II) . Eight Parties have comparable price and tax incidence rates for SLT for more than one point of time. India conducted health cost studies attributable to SLT for two rounds and Bangladesh for one round during 2004-2006. Parties to the Convention are obligated to carry out surveillance and research on SLT use and related indicators. This study showed that SLT use was widely prevalent among 92 per cent of Parties. Prior studies have also indicated that SLT use is a global epidemic [5] [6] [7] [8] [9] . There is now ample evidence from studies [5] [6] [7] 39 , including the present one, that SLT burden is mainly concentrated in developing world. Data gap on evidence collection on SLT-related indicators can partly be attributed to inadequate resources and capacities for surveillance and research in low-income countries as well as low-and middle-income countries 5 . There was lack of data for SLT use in eight per cent of the Parties. There could be different reasons for this data gap such as ignorance and lack of commitment for SLT control among many parties. Many data sources were not in public domain and many reports were in regional languages. Another notable finding was non-availability of recent data from many Parties.
Robust research, surveillance systems and monitoring programmes are critical to the success of addressing the global SLT epidemic. Our study had certain limitations. The data analysed in this study pertained only to the available data in English language literature and thus could be underrepresented. Comparability of data was also a major issue.
In conclusion, Parties (especially in SEAR and in low-and low-middle-income countries) should establish sustainable resources for periodic monitoring of the magnitude, patterns, determinants and related social, economic and health consequences of SLT use. Parties should contact and communicate with international partners to strengthen resources and build capacity for monitoring and research on specific tobacco control issues in their respective countries.
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